Parkinson's Disease

How can continuous dopaminergic delivery improve outcomes in PD? 0:51
How can continuous dopaminergic delivery improve outcomes in PD?
Eric Freire-Alvarez • 16 Sep 2022
Unmet needs across movement disorders 1:33
Unmet needs across movement disorders
Fabrizio Stocchi • 16 Sep 2022
Long term effects of treating levodopa-induced dyskinesia with sub-anesthetic ketamine 0:52
Long term effects of treating levodopa-induced dyskinesia with sub-anesthetic ketamine
Torsten Falk • 17 Sep 2022
Extending the efficacy of levodopa in patients with Parkinson’s disease 1:13
Extending the efficacy of levodopa in patients with Parkinson’s disease
Torsten Falk • 17 Sep 2022
Targeting oligomeric species to combat Parkinson’s disease 1:27
Targeting oligomeric species to combat Parkinson’s disease
Daniel Otzen • 5 Sep 2022
Targeting glycation as a potential therapeutic avenue in Parkinson’s disease 2:02
Targeting glycation as a potential therapeutic avenue in Parkinson’s disease
Daniel Otzen • 5 Sep 2022
Low-dose ketamine produces long-term reduction in levodopa-induced dyskinesia 3:22
Low-dose ketamine produces long-term reduction in levodopa-induced dyskinesia
Torsten Falk
PADOVA trial: prasinezumab in early Parkinson’s disease 1:34
PADOVA trial: prasinezumab in early Parkinson’s disease
Gennaro Pagano • 17 Sep 2022
Strategies to improve early diagnosis of Parkinson’s disease 1:20
Strategies to improve early diagnosis of Parkinson’s disease
Jaslovleen Kaur • 17 Sep 2022
Elucidating prognostic biomarkers in Parkinson’s disease 1:13
Elucidating prognostic biomarkers in Parkinson’s disease
Jaslovleen Kaur • 17 Sep 2022
How can mitochondrial dynamics and mitophagy affect neurodegeneration? 3:33
How can mitochondrial dynamics and mitophagy affect neurodegeneration?
Serge Przedborski • 16 Sep 2022
Identifying and characterizing non-motor fluctuations in PD 2:54
Identifying and characterizing non-motor fluctuations in PD
K. Ray-Chaudhuri • 17 Sep 2022
Current challenges in PSP management 2:24
Current challenges in PSP management
Rodolfo Savica • 16 Sep 2022
Investigations into managing non-motor fluctuations 2:33
Investigations into managing non-motor fluctuations
K. Ray-Chaudhuri • 17 Sep 2022
Advancements in cell therapies for Parkinson’s disease 3:30
Advancements in cell therapies for Parkinson’s disease
Serge Przedborski • 16 Sep 2022
Follow-up studies of long COVID in patients with Parkinson’s disease 1:48
Follow-up studies of long COVID in patients with Parkinson’s disease
Susanne Schneider • 19 Sep 2022
The content of VJNeurology is intended for healthcare professionals